JPRN-UMIN000010060已完成未知
Clinical efficacy and safety of a beta3-adrenoceptor agonist and an antimuscarinic agent in female patients with overactive overactive bladder: a randomized crossover study - Clinical comparison between miragegron and imidafenacin: a randomized crossover study
ara Medical University0 个研究点目标入组 100 人开始时间: 2013年2月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Postvoid residual urine 50 mL and more, 2. Active urinary tract infection, 3. Histories of malignant tumors in the lower urinary tract, 4. Histories of surgery for the lower urinary tract in the last 3 months
研究者
相似试验
进行中（未招募）
不适用
(VAPOR trial)Overactive bladderJPRN-jRCTs071190040Seki Narihito60
尚未招募
不适用
The effect of a beta-3 adrenergic receptor agonist on metabolic disease in humans.ACTRN12618001449224Baker Heart and Diabetes Institute60
尚未招募
不适用
The clinical study of beta 3-agonist (Betanis) for lower urinary tract symptoms mainly for overactive bladderlower urinary tract symptoms (overactive bladder)JPRN-UMIN000008084Dept. of Urology, Kyoto University Hospital100
已完成
2 期
Evaluation of safety and efficacy to abatacept treatment of patients with HBV-related acute liver failure.-Pilot StudyJPRN-UMIN000016148Hiroshima liver study group5
已完成
不适用
Efficacy and safety of long-acting beta-2 agonist and long-acting muscarinic antagonist combinations in patients with chronic obstructive pulmonary disease: meta-analysis of phase 3 randomized trialschronic obstructive pulmonary diseaseJPRN-UMIN000026496Showa University5,000